CK Life Sciences Int'l., (Holdings) Inc. 0775.HK
0775.HK
CK Life Sciences Int'l., (Holdings) Inc. 1672.HK
Ascletis Pharma Inc. 2616.HK
CStone Pharmaceuticals 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2171.HK
CARsgen Therapeutics Holdings Limited 2142.HK
HBM Holdings Limited 2509.HK
Qyuns Therapeutics Co., Ltd. 2256.HK
Abbisko Cayman Limited 1477.HK
Ocumension Therapeutics 2192.HK
Medlive Technology Co., Ltd.
CK Life Sciences Int'l., (Holdings) Inc. 1672.HK
Ascletis Pharma Inc. 2616.HK
CStone Pharmaceuticals 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 2171.HK
CARsgen Therapeutics Holdings Limited 2142.HK
HBM Holdings Limited 2509.HK
Qyuns Therapeutics Co., Ltd. 2256.HK
Abbisko Cayman Limited 1477.HK
Ocumension Therapeutics 2192.HK
Medlive Technology Co., Ltd.
Performance
| Periode | 0775.HK | 1672.HK | 2616.HK | 2315.HK | 2171.HK | 2142.HK | 2509.HK | 2256.HK | 1477.HK | 2192.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 18.42 % | 89.27 % | 174.90 % | 102.20 % | 35.40 % | 80.50 % | 221.56 % | 130.26 % | 61.01 % | 0.52 % |
| YTD | 119.51 % | 188.58 % | 181.63 % | 187.47 % | 83.90 % | 554.55 % | 314.02 % | 257.14 % | 68.42 % | 19.05 % |
| 1Y | 87.50 % | 592.59 % | 283.33 % | 218.56 % | 330.17 % | 920.47 % | 93.71 % | 305.93 % | 25.29 % | 31.07 % |
| 3Y | 45.16 % | 306.52 % | 93.28 % | -8.23 % | 30.09 % | 945.16 % | 18.12 % | 439.38 % | -19.50 % | 68.76 % |
| 5Y | 2.27 % | 206.56 % | -43.44 % | -8.23 % | -42.50 % | 17.60 % | 18.12 % | 27.02 % | -66.24 % | -62.71 % |
| 10Y | 21.62 % | -33.21 % | -46.35 % | -8.23 % | -42.50 % | 17.60 % | 18.12 % | 27.02 % | -79.24 % | -62.71 % |
| From the beginning | -69.05 % | -33.21 % | -46.35 % | -8.23 % | -42.50 % | 17.60 % | 18.12 % | 27.02 % | -79.24 % | -62.71 % |